Clustering based on adherence data

Por Kiwuwa-Muyingo, Sylvia, Oja, Hannu, Walker, Sarah A, Ilmonen, Pauliina, Levin, Jonathan, Todd, Jim
Publicado em 2011

XLF-Cernunnos promotes DNA ligase IV–XRCC4 re-adenylation following ligation

Por Riballo, Enriqueta, Woodbine, Lisa, Stiff, Thomas, Walker, Sarah A., Goodarzi, Aaron A., Jeggo, Penny A.
Publicado em 2009

ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling

Por Stiff, Thomas, Walker, Sarah A, Cerosaletti, Karen, Goodarzi, Aaron A, Petermann, Eva, Concannon, Pat, O'Driscoll, Mark, Jeggo, Penny A
Publicado em 2006

DNA-PK autophosphorylation facilitates Artemis endonuclease activity

Por Goodarzi, Aaron A, Yu, Yaping, Riballo, Enriqueta, Douglas, Pauline, Walker, Sarah A, Ye, Ruiqiong, Härer, Christine, Marchetti, Caterina, Morrice, Nick, Jeggo, Penny A, Lees-Miller, Susan P
Publicado em 2006

Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study

Por Gomo, Zvenyika AR, Hakim, James G, Walker, Sarah A, Tinago, Willard, Mandozana, Gibson, Kityo, Cissy, Munderi, Paula, Katabira, Elly, Reid, Andrew, Gibb, Diana M, Gilks, Charles F
Publicado em 2014

The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains

Por Mbisa, Jean L, Gupta, Ravi K, Kabamba, Desire, Mulenga, Veronica, Kalumbi, Moxmalama, Chintu, Chifumbe, Parry, Chris M, Gibb, Diana M, Walker, Sarah A, Cane, Patricia A, Pillay, Deenan
Publicado em 2011

Clinical Differences between Younger and Older Adults with HIV/AIDS Starting Antiretroviral Therapy in Uganda and Zimbabwe: A Secondary Analysis of the DART Trial

Por Parikh, Sujal M., Obuku, Ekwaro A., Walker, Sarah A., Semeere, Aggrey S., Auerbach, Brandon J., Hakim, James G., Mayanja-Kizza, Harriet, Mugyenyi, Peter N., Salata, Robert A., Kityo, Cissy M.
Publicado em 2013

Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks

Por Babiker, Abdel, Darbyshire, Janet, Pezzotti, Patrizio, Porter, Kholoud, Rezza, Giovanni, Walker, Sarah A, Beral, Valerie, Coutinho, Roel, Del Amo, Julia, Gill, Noël, Lee, Christine, Meyer, Laurence, Tyrer, Freya, Dabis, François, Thiébaut, Rodolphe, Lawson-Aye, Sylvie, Boufassa, Faroudy, Hamouda, Osamah, Fischer, Klaus, Pezzotti, Patrizio, Touloumi, Giota, Hatzakis, Angelos, Karafoulidou, Anastasia, Katsarou, Olga, Brettle, Ray, Del Romero, Jorge, Prins, Maria, Van Benthem, Birgit, Kirk, Ole, Pederson, Court, Hernández Aguado, Idelfonso, Pérez-Hoyos, Santiago, Eskild, Anne, Bruun, Johan N, Sannes, Mette, Sabin, Caroline, Johnson, Anne M, Phillips, Andrew N, Francioli, Patrick, Vanhems, Philippe, Egger, Mathias, Rickenbach, Martin, Cooper, David, Kaldor, John, Ashton, Lesley, Vizzard, Jeanette, Muga, Roberto, Day, Nicholas E, De Angelis, Daniela
Publicado no Int J Epidemiol (2002)